Motawi_2017_Metab.Brain.Dis_32_1519

Reference

Title : Coenzyme Q10 and niacin mitigate streptozotocin- induced diabetic encephalopathy in a rat model - Motawi_2017_Metab.Brain.Dis_32_1519
Author(s) : Motawi TK , Darwish HA , Hamed MA , El-Rigal NS , Aboul Naser AF
Ref : Metabolic Brain Disease , 32 :1519 , 2017
Abstract :

Diabetic encephalopathy is an important complication of diabetes characterized by cognitive impairment, neurochemical and structural abnormalities. This study aimed to investigate the effect of coenzyme Q10 (CoQ10) and niacin as well as their combination in the treatment of encephalopathy associated with streptozotocin (STZ)- induced diabetes in rats. Glibenclamide (reference diabetic drug) and donepezil hydrochloride (acetylcholinesterase inhibitor) were also evaluated. Diabetes was induced by a single intraperitoneal injection of STZ (60 mg/kg). One month after STZ injection, diabetic rats were treated with the aforementioned drugs for two weeks. The evaluation was done through measuring glucose level, total antioxidant capacity (TAC), interleukin 6 (IL6), DNA degradation as well as serotonin and noradrenaline as neurotransmitters. The present data illustrated that combining CoQ10 and niacin exhibiting the most potent effect in improving the measured parameters and ameliorating some of diabetes complications.

PubMedSearch : Motawi_2017_Metab.Brain.Dis_32_1519
PubMedID: 28560538

Related information

Citations formats

Motawi TK, Darwish HA, Hamed MA, El-Rigal NS, Aboul Naser AF (2017)
Coenzyme Q10 and niacin mitigate streptozotocin- induced diabetic encephalopathy in a rat model
Metabolic Brain Disease 32 :1519

Motawi TK, Darwish HA, Hamed MA, El-Rigal NS, Aboul Naser AF (2017)
Metabolic Brain Disease 32 :1519